Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.22.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Balance at Beginning of Year (in shares) at Feb. 02, 2019     238,100,000        
Balance at Beginning of Year at Feb. 02, 2019 $ 5,642.9 $ (65.3) $ 2.4 $ 2,602.7 $ (38.3) $ 3,076.1 $ (65.3)
Statement of Stockholders' Equity [Roll Forward]              
Net income 827.0         827.0  
Total other comprehensive income (loss) (1.5)       (1.5)    
Issuance of stock under Employee Stock Purchase Plan (in shares)     100,000        
Issuance of stock under Employee Stock Purchase Plan 9.4     9.4      
Exercise of stock options (in shares)     0        
Exercise of stock options 5.8     5.8      
Stock-based compensation, net (in shares)     400,000        
Stock-based compensation, net 36.5     36.5      
Repurchase of stock (in shares)     (1,900,000)        
Repurchase of stock (200.0)     (200.0)      
Balance at End of Year (in shares) at Feb. 01, 2020     236,700,000        
Balance at End of Year at Feb. 01, 2020 6,254.8   $ 2.4 2,454.4 (39.8) 3,837.8  
Statement of Stockholders' Equity [Roll Forward]              
Net income 1,341.9         1,341.9  
Total other comprehensive income (loss) 4.6       4.6    
Issuance of stock under Employee Stock Purchase Plan (in shares)     200,000        
Issuance of stock under Employee Stock Purchase Plan 10.0     10.0      
Exercise of stock options (in shares)     100,000        
Exercise of stock options 7.0     7.0      
Stock-based compensation, net (in shares)     400,000        
Stock-based compensation, net 67.0     67.0      
Repurchase of stock (in shares)     (4,000,000.0)        
Repurchase of stock (400.0)   $ (0.1) (399.9)      
Balance at End of Year (in shares) at Jan. 30, 2021     233,400,000        
Balance at End of Year at Jan. 30, 2021 7,285.3   $ 2.3 2,138.5 (35.2) 5,179.7  
Statement of Stockholders' Equity [Roll Forward]              
Net income 1,327.9         1,327.9  
Issuance of stock under Employee Stock Purchase Plan (in shares)     100,000        
Issuance of stock under Employee Stock Purchase Plan $ 10.4     10.4      
Exercise of stock options (in shares) 93,594   100,000        
Exercise of stock options $ 7.4     7.4      
Stock-based compensation, net (in shares)     700,000        
Stock-based compensation, net 37.5     37.5      
Repurchase of stock (in shares)     (9,200,000)        
Repurchase of stock (950.0)   $ (0.1) (949.9)      
Balance at End of Year (in shares) at Jan. 29, 2022     225,100,000        
Balance at End of Year at Jan. 29, 2022 $ 7,718.5   $ 2.2 $ 1,243.9 $ (35.2) $ 6,507.6